ANI Pharmaceuticals reported $436.76M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
AbbVie USD 1.46B 1.86B Mar/2025
ANI Pharmaceuticals USD 436.76M 18.14M Jun/2025
Aurora Cannabis CAD 588.68M 15.76M Jun/2025
Canopy Growth CAD 488.98M 102.49M Jun/2025
Eli Lilly USD 18.27B 2.43B Jun/2025
Hikma Pharmaceutical USD 2.32B 35M Dec/2024
Knight Therapeutics CAD 773.91M 11.11M Sep/2024
Novartis USD 42.05B 1.99B Jun/2025
Perrigo USD 4.47B 108.3M Jun/2025
Sun Pharmaceuticals INR 722.18B 28.38B Mar/2025
Teva Pharmaceutical Industries USD 6.83B 572M Jun/2025